Exelixis Inc
NASDAQ:EXEL

Watchlist Manager
Exelixis Inc Logo
Exelixis Inc
NASDAQ:EXEL
Watchlist
Price: 33.29 USD -1.16% Market Closed
Market Cap: 9.5B USD
Have any thoughts about
Exelixis Inc?
Write Note

P/FCFE
Price to FCFE

22
Current
19.8
Median
23.4
Industry
Higher than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
22
=
Market Cap
9.5B USD
/
FCFE
432.6m USD
All Countries
Close
Market Cap P/FCFE
US
Exelixis Inc
NASDAQ:EXEL
9.5B USD 22
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 222 687.7
US
Abbvie Inc
NYSE:ABBV
310.3B USD 12.4
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 11.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD -77.4
US
Epizyme Inc
F:EPE
94.1B EUR -425.8
AU
CSL Ltd
ASX:CSL
134.4B AUD 76.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 23.3
US
Seagen Inc
F:SGT
39.3B EUR -58.5
NL
argenx SE
XBRU:ARGX
35.8B EUR -112.9

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More